Cancer prognosis is importantly determined by immunosurveillance efficacy, which is critically influenced by the expression of immune checkpoint-related genes, such as PD-L1, CTLA-4, and LAG-3, in cancer cells [16]. This evidence concerns the gene CTLA4 and cancer.